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REVIEW CURRENTOPINION Assessing nutritional status in cancer: role of the
Patient-Generated Subjective Global Assessmentwww.co-clinicalnutrition.com¨ a,b a,cHarriet Jager-Wittenaar and Faith D. OtteryPurpose of review
The Scored Patient-Generated Subjective Global Assessment (PG-SGA) is used internationally as the
reference method for proactive risk assessment (screening), assessment, monitoring and triaging for
interventions in patients with cancer. This review aims to explain the rationale behind and data supporting
the PG-SGA, and to provide an overview of recent developments in the utilization of the PG-SGA and the
PG-SGA Short Form.
Recent findings
The PG-SGA was designed in the context of a paradigm known as ‘anabolic competence’. Uniquely, the
PG-SGA evaluates the patient’s status as a dynamic rather than static process. The PG-SGA has received
new attention, particularly as a screening instrument for nutritional risk or deficit, identifying treatable
impediments and guiding patients and professionals in triaging for interdisciplinary interventions. The
international use of the PG-SGA indicates a critical need for high-quality and linguistically validated
translations of the PG-SGA.
Summary
As a 4-in-1 instrument, the PG-SGA can streamline clinic work flow and improve the quality of interaction
between the clinician and the patient. The availability of multiple high-quality language versions of the
PG-SGA enables the inclusion of the PG-SGA in international multicenter studies, facilitating meta-analysis
and benchmarking across countries.
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Diagnosis and treatment of malnutrition and dis-
turbed metabolism are of critical importance in
patients with cancer. Because of the disease and
the effects of anticancer therapies, many patients
with cancer are at risk formalnutrition.Malnutrition
is associated with poorer prognosis and decreased
quality of life [1]. Nutritional assessment serves as
the basis for the malnutrition diagnosis, which also
includes cause, severity and type of malnutrition [2].
The Scored Patient-Generated Subjective Global
Assessment (PG-SGA; Copyright FD Ottery, 1996,
2001, 2005, 2006 and 2015) is broadly used in both
clinical practice and in academic research as the
referencemethod for assessing the nutritional status
of patients with cancer. One of the considerations
underlying this wide acceptance is the fact that the
PG-SGA is a 4-in-1 instrument: nutritional screen,
assessment, interventional triage and an instrument
to monitor interventional success. The PG-SGA is
recommended in various countries and/or includedin various national guidelines for nutrition in oncol-
ogy, for example Australia, Brazil, The Netherlands
[3], United Kingdom [4] and the United States. It is
not, however, an oncology-specific instrument.Volume 20  Number 5  September 2017
KEY POINTS
 The PG-SGA was designed in the context of a
paradigm known as ‘anabolic competence’ and
addresses a multimodality approach, including
nutrition, hormonal milieu and exercise.
 The PG-SGA and PG-SGA Short Form cover all
domains of the conceptual definitions of malnutrition, as
defined by ESPEN and ASPEN.
 The PG-SGA and PG-SGA Short Form are validated
and sensitive instruments that can easily be used as
nutritional screen completed by patients (Short Form),
and as nutritional screen, assessment or monitoring
instrument by trained professionals (full or Short Form).
 The PG-SGA facilitates interdisciplinary planning across
the patient’s cancer care continuum by triaging for
interventions, for example dietitian, nurse, physician or
other relevant individuals in the clinical care process.
 The growing number of translated and culturally
adapted versions of the PG-SGA enables global meta-
analysis of data, as well as benchmarks for malnutrition
outcomes globally.
Role of PG-SGA in cancer Jager-Wittenaar and OtterySince the introduction of the PG-SGA in the
1990s [5], it has been validated and utilized in both
cancer and non-cancer patient populations interna-
tionally. Numerous studies have shown the associ-
ation betweenPG-SGA scores and specific nutritional
parameters, for example weight loss, BMI, skinfold
measures and hand grip strength [6]. Both earlier
and recent data have demonstrated the PG-SGA’s
ability to predict clinical outcomes, for example sur-
vival, postoperative complications, length of stay,





,9–13]. The PG-SGA is sensitive to changes in
nutritional status over time, for example in response
to nutritional interventions [14].
Recently, the PG-SGA (full and Short Form) has
received new attention, particularly as a screening
instrument for nutritional risk or deficit. The PG-SGA
is often described as a nutritional assessment instru-
ment to diagnosemalnutrition, and a recent system-
atic review showed that both the PG-SGA and
PG-SGAShort Form(i.e. Boxes1–4) cover all domains
of the conceptual definitions of malnutrition, as
defined by the European Society for Clinical Nutri-
tion and Metabolism (ESPEN) and the American
Society for Parenteral and Enteral Nutrition (ASPEN)
[15
&
]. Current interest also focuses on the PG-SGA’s
ability to identify treatable impediments and toguide
patients and professionals in triaging for interdisci-
plinary interventions. The PG-SGA not only ident-
ifies existing malnutrition, but also risk factors that1363-1950 Copyright  2017 The Author(s). Published by Wolters Kluwepredispose the patient to future malnutrition. The
PG-SGA’s triaging system includes nutritional,
pharmacologic, exercise and other interventions to
facilitate proactive identification, prevention and
treatment of malnutrition in at-risk patients.HISTORICAL BASIS
The PG-SGA was developed as a modification of the
original clinician-generated subjective global assess-
ment (SGA) developed at the University of Toronto
by Drs. Jeejeebhoy, Baker and Detsky. The original
SGA was based on the hypothesis that restoration of
food intake can rapidly reduce the risks associated
with malnutrition. Specifically, it was hypothesized
that if nutrient intake can be restored to optimal
levels to meet requirements, the risk of compli-
cation is lower, even though the patient may be
still wasted and underweight. Changing from a
clinician-generated to patient-generated approach
aimed to address patient-centric concerns, stream-
line the clinic flow across the care continuum (inpa-
tient, outpatient, home care and palliative care) and
to optimize time for patient–clinician interaction.
As patients complete the form prior to interacting
with their clinician that is any professional who is
involved in the clinical care of the patients with
patient self-identification of those issues that impact
him/her, clinic flow can be shortened with accom-
panying improvement in quality and productivity
of interaction.
The PG-SGA was originally developed as a one-
page instrument that globally assessed a patient in
terms of nutritional risk and nutritional deficit and
was unscored. The PG-SGAwas subsequently scored,
to stimulate its use in clinical and clinical trial
settings and to limit interobserver variability. A
scoring system was developed based on combined
input from both medical/oncologic and nutritional
perspectives, with the following considerations
included, particularly for Boxes 1–4:(1)r HeaPatient perception and patient-reported con-
cerns(2) Variables of risk for malnutrition or prediction
of degree of nutritional deficit(3) Options for intervention for nutritional intake
and nutrition impact symptoms to prevent
or reverse malnutrition and weight loss, for
example behavioral, educational and pharmaco-
logic interventions(4) Known prognostic variables, such as degree and
acuteness of weight loss and performance status,
for example a score of at least 2(5) A scoring schema of 0–4 points, consistent with
scoring used throughout oncology and inlth, Inc. www.co-clinicalnutrition.com 323
Table 1. Relationship between Patient-Generated Subjective Global Assessment scores and outcomes (n¼1402), published
between 2015 and 2017
Author
Year of
publication Setting Population (N) Outcomes
Rodrigues
et al. [7&&]
2015 Hospital 146 women with
gynecologic cancer
Significant association between PG-SGA numerical score
(>10 points versus 0–10 points) and mortality within
1 year [odds ratio¼30.7; 95% confidence interval
(CI): 11.8–79.4]
Significant association between PG-SGA Categories and
mortality within 1 year (PG-SGA C versus A: hazard
ratio¼2.04 95% CI: 1.03–4.05; P¼0.041)
Significant association between PG-SGA Categories and
length of hospital stay [PG-SGA B (median length of stay
8.5 days; range 1–51 days) or C (median 12 days; range
2–32 days) versus A (median 7 days; range 2–17 days);
P¼0.002]




72 h of admission)
Significant association between PG-SGA Categories (PG-SGA
C versus A) and increased hospitalization costs (27.5%;
95% CI: 14.0–41.1%; P<0.001)





Significant association between PG-SGA Categories (PG-SGA
C versus A/B) and overall survival (hazard ratio¼2.73;
95% CI: 1.73–4.29; P<0.001)
Barata et al. [10] 2017 Hospital 37 non-resectable
lung cancer patients
Significant association between PG-SGA Categories (PG-SGA
A, B/C) and hand grip strength (P¼0.026; 95% CI:
0.023–0.029)
Ha¨rter et al. [11] 2017 Hospital 60 oncology patients
admitted for
elective surgery
Significant association between PG-SGA numerical score (4
versus 0–3 points) and severe postoperative complications
(P¼0.020)
Kim et al. [12] 2017 Hospital 216 patients with
multiple myeloma
(prior to start of
chemotherapy
Significant association between PG-SGA numerical score (9
versus 0–3 points) and overall survival (hazard
ratio¼2.347; 95% CI: 1.271–4.334; P¼0.006)
El Ghammaz
et al. [12]





Significant association between PG-SGA Categories (PG-SGA
B/C versus A) at admission (hazard ratio¼21.542; 95%
CI¼1.163–399.076; P¼0.039) and day 180 post-
transplantation (hazard ratio¼281.879; 95% CI¼1.642–
48.399; P¼0.032) and overall survival, respectively
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324toxicity criteria, indicating normal or minimal
impact on nutritional status or risk (0); mild
impact (1); moderate impact (2); severe impact
(3) and potentially life-threatening impact (4)(6) Total PG-SGA score predominantly from patient
input rather than clinician evaluationANABOLISM VERSUS CATABOLISM: THE
CORE TENET OF THE PATIENT-
GENERATED SUBJECTIVE GLOBAL
ASSESSMENT
The PG-SGA was designed in the context of a para-
digm known as ‘anabolic competence’, that is the
state that optimally supports protein synthesis and
lean body mass, global aspects of muscle and
organ function and immune response [6]. Thewww.co-clinicalnutrition.comparadigm of anabolic competence depicts the
primary components of optimal interventions:
nutrition, hormonal milieu (including classic
hormones and cytokines) and exercise (Fig. 1).
Although defined in the 1990s, this integrative
approach is increasingly being appreciated as critical
in shaping how we think of intervention during
cancer treatment, particularly in the context of
optimizing oncologic outcomes and quality of
survivorship.
The PG-SGA addresses a multimodality and
interdisciplinary approach. The Boxes are comp-
lementary to each other, as each addresses factors
that place the patient at risk for nutritional deficit or
poorer outcome. In addition, the PG-SGA includes
catabolic factors hindering protein synthesis and
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FIGURE 1. Anabolic competence: core tenet of the PG-SGA
nutritional intervention. Anabolic competence is that state
which optimally supports protein synthesis and lean body
mass, global aspects of muscle and organ function and
immune response [8&]. PG-SGA, Patient-Generated
Subjective Global Assessment.
Role of PG-SGA in cancer Jager-Wittenaar and Otterythe use of corticosteroids (Worksheet 3). Identifying
these catabolic factors has therapeutic implications:
fever increases nutritional requirements correlated
with degree and duration of fever, and, depending
on dose/route of administration/duration, the use
of corticosteroids also increases protein require-
ments. Unfortunately, in daily practice, the use of
corticosteroids may be overlooked as a contributing
catabolic factor.
In contrast to other screening and assessment
instruments, the PG-SGA evaluates the patient’s
status as a dynamic rather than static process.
Although weight history is included in many
other screening and assessment instruments, the
PG-SGA uniquely uses weight history as an indicator
of anabolism or catabolism. By scoring acute
weight change in addition to intermediate or
chronic weight change, the PG-SGA distinguishes
a ‘U-curved shape’ of weight from a linear decrease
in body weight. Addressing acute weight change
characterizes the specificity of the PG-SGA as com-
pared to other screening and assessment instru-
ments. In a recent Portuguese study, long-stay
nursing home residents were evaluated by both
PG-SGA and Mini Nutritional Assessment (MNA).
Interestingly, half of patients categorized as ‘Well
nourished’ by PG-SGA were categorized as ‘Risk of
malnutrition’ by MNA [16]. This discrepancy can be
explained by differences in the scoring of weight
history: whereas the PG-SGA ‘corrects’ for short-1363-1950 Copyright  2017 The Author(s). Published by Wolters Kluweterm weight stabilization or weight gain, the MNA
does not ‘correct’ for recent improvements.STRUCTURE OF THE PATIENT-GENERATED
SUBJECTIVE GLOBAL ASSESSMENT
The PG-SGA was early in adopting the concept that
the patient – not the clinician or carer – is better at
reporting what she/he is experiencing. The PG-SGA
empowers patients (and indirectly their carers)
by asking them about matters that can often be
overlooked, or that can be seen to be of lesser
importance. The PG-SGA identifies variables that
patients may avoid addressing so as not to be seen
as complainers; because they do not know that
intervention is possible; or because they believe that
the symptoms may mean the cancer is worsening or
returning. The variety of factors addressed by the
Boxes and Worksheets (Table 2) characterizes the
PG-SGA as a global assessment of patient risk, rather
than solely nutritional deficit.
The PG-SGA consists of two components. First,
the patient-generated component, that is Boxes 1–4
(Fig. 2A), officially known and separately used as the
PG-SGA Short Form, was designed to be completed
by the patient and to reflect approximately 80–90%
of the score [5]. The PG-SGA Short Form has been
validated as independent screening tool [17]. Sec-
ond, the items in the professional component
(Fig. 2B) were developed as Worksheets to provide
self-contained training and to raise awareness of
contributors tomalnutrition that in clinical practice
may easily be overlooked, for example fever and
corticosteroids [5]. The five Worksheets are com-
pleted by the healthcare professional, which may
include the dietitian, nurse, physician, physiothera-
pist or others involved in the patient’s clinical care.PATIENT-GENERATED SUBJECTIVE
GLOBAL ASSESSMENT AS 4-IN-1
INSTRUMENT: SCREEN, ASSESSMENT,
TRIAGE AND MONITORING
Although the PG-SGAhasmostly been described as a
nutritional assessment tool [2], the PG-SGA should
be considered a 4-in-1 instrument: nutritional
screen, assessment, interventional triage and an
instrument to monitor interventional success. As
such, the PG-SGA has the advantage of not only
being able to diagnose a problem, but also to effi-
ciently guide appropriate intervention and gauge
improvement.
The inclusion of nutrition impact symptoms
and other factors (Box 3) as risk factors may explain
why the PG-SGA Short Form may categorize more
patients at risk when compared to other screeningr Health, Inc. www.co-clinicalnutrition.com 325
Table 2. Explanation of the Patient-Generated Subjective Global Assessment’s Boxes and Worksheets
Box or Worksheet Explanation
Box 1 Chronic, intermediate and acute weight change
Box 2 Changes in amount/type/consistency of food intake
Box 3 Symptoms/impediments that negatively influence food intake/absorption/utilization of nutrients
Box 4 Activities and function based on the Eastern Cooperative Oncology Group (ECOG) performance status, converted to
layman’s language
Worksheet 1 Instructions on scoring of percentage weight loss (Box 1)
Worksheet 2 Conditions that may increase nutritional risk or requirements
Worksheet 3 Metabolic stress, for example fever (degree/duration) and corticosteroids (type/dose)
Worksheet 4 Scoring of muscle status (deficit/loss of muscle mass/tone), fat stores and fluid status, based on the nutrition-focused
physical examination
Worksheet 5 Overall patient global assessment categorization, utilizing the findings of Boxes 1–4 and the physical examination
(Worksheet 4). Categories: Stage A¼well nourished, or ‘not undernourished’; Stage B¼moderately malnourished
or suspected malnutrition; or Stage C¼ severely malnourished
Assessment of nutritional metabolic statusinstruments. An exploratory study in Dutch head
and neck cancer patients showed that 28% of
patients scored at least 9 points, and were con-
sidered ‘at high risk’ by the PG-SGA Short Form,
compared to 21% categorized as ‘high risk’ accord-
ing to the Malnutrition Universal Screening Tool
(MUST) or Short Nutritional Assessment Question-
naire (SNAQ). The PG-SGA Short Form also had
better diagnostic accuracy than the MUST and
SNAQ, using the full PG-SGA as reference [18].
It is hypothesized that identifying nutrition
impact symptoms, especially in an early stage
during the cancer continuum, may facilitate pro-
active malnutrition prevention. For example, a
patient may not have lost any significant weight
on the initial assessment with an Eastern Coopera-
tive Oncology Group performance status of 0. If
the patient checks off several nutrition impactFIGURE 2. (a) Patient component of the PG-SGA, that is PG-S
PG-SGA, Patient-Generated Subjective Global Assessment.
326 www.co-clinicalnutrition.comsymptoms for which she/he does not receive timely
intervention, nutritional status and quality of life
are at risk for deterioration. Historically, studies
utilizing the PG-SGA have predominantly been
observational. Future clinical interventions trials
should elucidate the impact of proactively address-
ing risk factors in the prevention of malnutrition or
stabilization of nutritional status.
The PG-SGA (full or Short Form) also facilitates
patient monitoring over time. The scoring of the
PG-SGA (Table 3) was added to the PG-SGA
Categories to identify incremental changes in the
patient’s global status. Earlier data from Australia
confirmed that a change in PG-SGA score of9.0
points [95% confidence interval (CI): 7.2–10.9]
was required to change by one category (Stages A,
B or C) – improvement or deterioration – and
showed that risk status may change even withoutGA Short Form. (b) Professional component of the PG-SGA.
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Box 1 – weight (maximum 5 points) – ADDITIVE
Self-reported weight change (1 month or
6 monthsa)
0–4
Self-reported weight change in past 2 weeks 0–1
Box 2 – food intake (maximum 4 points) – highest score
Self-rated food intake during the past month 0–1
Self-reported actual type of food intake 0–4
Box 3 – self-reported symptoms affecting eating (maximum
24 points) – ADDITIVE
No problems eating 0










Smells bother me 1
Feel full quickly 1
Fatigue 1
Other 1
Box 4 – activities and function (maximum 3 points) – HIGHEST
SCORE
Self-rated activity level 0–3
Worksheet 1 – scoring weight loss – ADDITIVE
Is included in point score of Box 1
Worksheet 2 – disease and its relation to nutritional requirements
(no maximum) – ADDITIVE
Cancer 1
AIDS 1
Pulmonary or cardiac cachexia 1
Chronic renal insufficiency 1
Presence of decubitus, open wound or fistula 1
Presence of trauma 1
Age greater than 65 1
Other 1 for each
condition
Worksheet 3 – metabolic demand (maximum 6 points) – additive
Fever intensity and fever duration 0–3
Corticosteroids type and dose 0–3
Worksheet 4 – physical examination (maximum 3 points for the




aTo determine score, use 1-month weight data if available. Use 6-month data,
only if there is no 1-month weight data.
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1363-1950 Copyright  2017 The Author(s). Published by Wolters Kluwesignificant changes in the patient’s nutritional sta-
tus. The PG-SGA point score is also the basis for
triaging for specific interdisciplinary interventions,
including patient education.PRACTICAL CONSIDERATIONS ON THE
USE OF THE PATIENT-GENERATED
SUBJECTIVE GLOBAL ASSESSMENT
As 80–90% of the scoring results from the first four
Boxes, it is consistent that the PG-SGA Short
Form shows high sensitivity and specificity when
compared to the full PG-SGA [17,18]. An Australian
study in ambulatory patients undergoing anticancer
treatment found a sensitivity and specificity of 80
and 72%, respectively, while using a PG-SGA Short
Form risk cutoff score of at least 3 points [17]. A
Dutch study in head and neck cancer patients that
used a higher cutoff, that is at least 9 points, indi-
cating critical need for intervention as described in
the PG-SGA triage for nutritional recommendations,
showed a sensitivity and specificity of 73 and 100%,
respectively [18]. The good sensitivity and speci-
ficity of the PG-SGA Short Form supports its use
as screening and monitoring instrument.
At the 2016 ESPEN Congress, it was articulated
that screening should use simple questions that can
be quickly answered by the patients, relatives or
carers [19]. As early as the 1990s, the PG-SGA was
reported as easy to use. Recent data collected during
the PG-SGA translation and cultural adaptation
process to the Dutch setting confirmed that patients
consider the PG-SGA Short Form comprehensible
and easy [20]. The PG-SGA Short Form has also been
reported as a quick instrument to complete. It gener-
ally takes the patient less than 5 min, and this is
often completed prior to seeing the healthcare pro-
vider. Interestingly, the Dutch study in head and
neck cancer patients also showed that completing
the PG-SGA Short Form may increase the patient’s
awareness of malnutrition risk [21].
Although patients perceive the PG-SGA as com-
prehensible and easy, PG-SGA-naive professionals
may perceive the professional component, especi-
ally the physical examination, as comprehensible
but difficult [20]. Studies in the Netherlands and
Portugal have shown that improving PG-SGA
knowledge, for example by a training course, sig-
nificantly improves perceived difficulty of the
PG-SGA [22,23]. Training may tackle potential bar-
riers in performing the physical examination, but
may also ensure reliability. In an Australian study
in 189 adult inpatients, 16 dietitians trained in
use of the PG-SGA showed good inter-rater reliabi-
lity (intraclass correlation coefficient ¼ 0.901;
P<0.001) [24].r Health, Inc. www.co-clinicalnutrition.com 327
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TRANSLATION AND CULTURAL
ADAPTATION
With PG-SGA use internationally, there is a critical
need for high-quality and linguistically validated
translations of the PG-SGA. A high-quality trans-
lation of the PG-SGA can be defined as a translation
that hasmaintained conceptual, semantic and oper-
ational equivalence to the original English PG-SGA.
Since 2014, all new PG-SGA language versions are
developed following a ‘translation and cultural
adaptation process’, based on the Principles of Good
Practice for the Translation and Cultural Adaptation
Process for PRO Measures (ISPOR). The Dutch [20]
and Portuguese [25] PG-SGA are the first two ver-
sions of the PG-SGA that have been developed
according to the ISPOR Principles and are available
for download (www.pt-global.org). Multiple official
new PG-SGA translations will become available, for
example Brazilian, Danish, French, German, Italian,
Japanese, Norwegian, Persian, Polish, Swedish and
Thai.
The availability of multiple high-quality lang-
uage PG-SGA versions has numerous implications
for both clinical practice and the research setting.
For example, in addition to its use on the local level,
availability of the PG-SGA across the globe also ena-
bles the inclusion of the PG-SGA in international
multicenter studies, facilitating meta-analysis and
benchmarking across countries.CONCLUSION
The scored PG-SGA (including the PG-SGA Short
Form) is used internationally as the reference
method for proactive risk assessment (screening),
assessment, monitoring and triaging for interven-
tions in patients with cancer. Studies have consist-
ently confirmed high sensitivity and specificity and
the ability to predict both adverse and improved
clinical outcomes. Importantly, as the majority
input is patient-generated, the use of the PG-SGA
can streamline clinic work flow and improve the
quality of interaction between the clinician and
the patient.
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